메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
To generate new scaffold candidates as highlyselective and potent cyclin-dependent kinase (CDK) inhibitors,structure-based drug screening was performed utilizing 3Dpharmacophore conformations of known potent inhibitors. Asa result, CR229 (6-bromo-2,3,4,9-tetrahydro-carbolin-1-one)was generated as the hit-compound. A computational dockingstudy using the X-ray crystalographicstructure of CDK2 incomplex with CR229 was evaluated. This predicted bindingmode study of CR229 with CDK2 demonstrated that CR229interacted effectively with the Leu83 and Glu81 residues in theATP-binding pocket of CDK2 for the posible hydrogen bondformation. Furthermore, biochemical studies on inhibitoryeffects of CR229 on various kinases in the human cervicalcancer HeLa cells demonstrated that CR229 was a potentinhibitor of CDK2 (IC50: 3M), CDK1 (IC50: 4.9M), andCDK4 (IC50: 3M), yet had much less inhibitory effect (IC50:>20 M) on other kinases, such as casein kinase 2-α1 (CK2-α1), protein kinase A (PKA), and protein kinase C (PKC).Acordingly, these data demonstrate that CR229 is a potentCDK inhibitor with anticancer efficacy.

목차

등록된 정보가 없습니다.

참고문헌 (27)

참고문헌 신청

함께 읽어보면 좋을 논문

논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0